Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels

Contraception

Volumn 86, Issue 5, 2012, Pages 452-457

  Kaunitz, Andrew M ^a   Bissonnette, François ^b   Monteiro, Ilza ^c   Lukkari Lax, Eeva ^d   Desanctis, Yoriko ^e   Jensen, Jeffrey ^f  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d Bayer Oy   (Finland)

^e Bayer Healthcare Inc   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Ferritin; Hemoglobin; Levonorgestrel releasing intrauterine system; Medroxyprogesterone acetate; Menorrhagia

Indexed keywords

FERRITIN; HEMOGLOBIN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FERRITIN BLOOD LEVEL; HEAVY MENSTRUAL BLEEDING; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION;

ADULT; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; FERRITINS; HEMOGLOBINS; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MENORRHAGIA;

EID: 84867081756     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.07.018     Document Type: Article

References (21)

1. National Collaborating Centre for Women's and Children's Health. Heavy menstrual bleeding clinical guideline, January 2007. Commissioned by the National Institute for Health and Clinical Excellence. Available from: http://www.nice.org.uk/nicemedia/pdf/CG44FullGuideline.pdf (Accessed 4 Feb, 2011).
2. A.M. McCausland, and V.M. McCausland Long-term complications of endometrial ablation: cause, diagnosis, treatment, and prevention J Minim Invasive Gynecol 14 2007 399 406
3. National Health Committee New Zealand Working Party. Guidelines for the management of heavy menstrual bleeding, 1998. Available from: http://www.nzgg.org.nz/guidelines/0032/HMB-fulltext.pdf (Accessed 7 July, 2010).
4. T.E. Nieboer, N. Johnson, and D. Barlow Surgical approach to hysterectomy for benign gynaecological disease Cochrane Database Syst Rev 2006 CD003677
5. S. Zarek, and H.T. Sharp Global endometrial ablation devices Clin Obstet Gynecol 51 2008 167 175
6. J. Marjoribanks, A. Lethaby, and C. Farquhar Surgery versus medical therapy for heavy menstrual bleeding Cochrane Database Syst Rev 2006 CD003855
7. A.M. Kaunitz, and P. Inki The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review Drugs 72 2012 193 215
8. G.A. Irvine, M.B. Campbell-Brown, M.A. Lumsden, A. Heikkila, J.J. Walker, and I.T. Cameron Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia Br J Obstet Gynaecol 105 1998 592 598
9. A.M. Kaunitz, F. Bissonnette, I. Monteiro, E. Lukkari-Lax, C. Muysers, and J.T. Jensen Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial Obstet Gynecol 116 2010 625 632
10. P.C. Reid, and S. Virtanen-Kari Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts BJOG 112 2005 1121 1125
11. A.M. Kaunitz, S. Meredith, P. Inki, A. Kubba, and L. Sanchez-Ramos Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis Obstet Gynecol 113 2009 1104 1116
12. L. Hallberg, and L. Nilsson Determination of menstrual blood loss Scand J Clin Lab Invest 16 1964 244 248
13. W. Guy ECDEU Assessment Manual for Psychopharmacology 1976 U.S. Department of Health, Education, and Welfare Rockville, MD
14. T. Kucuk, and K. Ertan Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers Clin Exp Obstet Gynecol 35 2008 57 60
15. A. Kriplani, V. Kulshrestha, N. Agarwal, and S. Diwakar Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate J Obstet Gynaecol 26 2006 673 678
16. L. Fedele, S. Bianchi, R. Raffaelli, A. Portuese, and M. Dorta Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device Fertil Steril 68 1997 426 429
17. B. Xiao, S.C. Wu, J. Chong, T. Zeng, L.H. Han, and T. Luukkainen Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia Fertil Steril 79 2003 963 969
18. J.K. Andersson, and G. Rybo Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia Br J Obstet Gynaecol 97 1990 690 694
19. I. Monteiro, L. Bahamondes, J. Diaz, M. Perrotti, and C. Petta Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study Contraception 65 2002 325 328
20. K. Andersson, V. Odlind, and G. Rybo Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial Contraception 49 1994 56 72
21. A. Jacobs, F. Miller, M. Worwood, M.R. Beamish, and C.A. Wardrop Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload Br Med J 4 1972 206 208